JP2009535417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535417A5 JP2009535417A5 JP2009509982A JP2009509982A JP2009535417A5 JP 2009535417 A5 JP2009535417 A5 JP 2009535417A5 JP 2009509982 A JP2009509982 A JP 2009509982A JP 2009509982 A JP2009509982 A JP 2009509982A JP 2009535417 A5 JP2009535417 A5 JP 2009535417A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- inhibitor
- agent according
- day
- crofelemer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 36
- 229940124597 therapeutic agent Drugs 0.000 claims 36
- 239000003112 inhibitor Substances 0.000 claims 26
- 229920001393 Crofelemer Polymers 0.000 claims 13
- 229940047615 crofelemer Drugs 0.000 claims 13
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical group C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 10
- 241000894007 species Species 0.000 claims 8
- 208000023505 abnormal feces Diseases 0.000 claims 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 6
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims 6
- 206010012735 Diarrhoea Diseases 0.000 claims 6
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims 6
- 102000008371 intracellularly ATP-gated chloride channel activity proteins Human genes 0.000 claims 6
- 230000028327 secretion Effects 0.000 claims 6
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical group C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 claims 5
- 241001246270 Calophyllum Species 0.000 claims 5
- 229920001991 Proanthocyanidin Polymers 0.000 claims 5
- XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 claims 4
- 241001448862 Croton Species 0.000 claims 4
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims 4
- 229920002770 condensed tannin Polymers 0.000 claims 4
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims 4
- ZWJINEZUASEZBH-UHFFFAOYSA-N fenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC=C1 ZWJINEZUASEZBH-UHFFFAOYSA-N 0.000 claims 4
- -1 remacalim Chemical compound 0.000 claims 4
- HAZOZRAPGZDOEM-UHFFFAOYSA-N 2-aminoacetohydrazide Chemical compound NCC(=O)NN HAZOZRAPGZDOEM-UHFFFAOYSA-N 0.000 claims 3
- JIMHYXZZCWVCMI-ZSOIEALJSA-N 4-[(z)-[4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1\C=C/1C(=O)N(C=2C=C(C=CC=2)C(F)(F)F)C(=S)S\1 JIMHYXZZCWVCMI-ZSOIEALJSA-N 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 claims 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 claims 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims 2
- ZNGSVRYVWHOWLX-KHFUBBAMSA-N (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;hydrate Chemical compound O.CN[C@@H](C)[C@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 ZNGSVRYVWHOWLX-KHFUBBAMSA-N 0.000 claims 2
- DHVJQUFZGZOFFY-UHFFFAOYSA-N (6-amino-2-imino-4-piperidin-1-ylpyrimidin-1-yl) hydrogen sulfate Chemical compound N=C1N(OS(O)(=O)=O)C(N)=CC(N2CCCCC2)=N1 DHVJQUFZGZOFFY-UHFFFAOYSA-N 0.000 claims 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 claims 2
- ODUOJXZPIYUATO-UHFFFAOYSA-N 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic acid (phenylmethyl) ester Chemical compound C=1C=CC=CC=1COC(=O)CNC(=O)C(CSC(=O)C)CC1=CC=CC=C1 ODUOJXZPIYUATO-UHFFFAOYSA-N 0.000 claims 2
- ZTGKHKPZSMMHNM-UHFFFAOYSA-N 3-(2-phenylethenyl)benzene-1,2-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC(C=CC=2C=CC=CC=2)=C1S(O)(=O)=O ZTGKHKPZSMMHNM-UHFFFAOYSA-N 0.000 claims 2
- WBSMIPAMAXNXFS-UHFFFAOYSA-N 5-Nitro-2-(3-phenylpropylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCCC1=CC=CC=C1 WBSMIPAMAXNXFS-UHFFFAOYSA-N 0.000 claims 2
- YUFCOOWNNHGGOD-UMMCILCDSA-N 8-bromo-3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1Br YUFCOOWNNHGGOD-UMMCILCDSA-N 0.000 claims 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical class C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims 2
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 claims 2
- INMBONSHXVMDSX-UHFFFAOYSA-N [amino-[(2,6-dimethylphenyl)carbamoylamino]methylidene]-methylazanium;chloride Chemical compound Cl.CN=C(N)NC(=O)NC1=C(C)C=CC=C1C INMBONSHXVMDSX-UHFFFAOYSA-N 0.000 claims 2
- 206010000059 abdominal discomfort Diseases 0.000 claims 2
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 claims 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims 2
- 235000005487 catechin Nutrition 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229950001002 cianidanol Drugs 0.000 claims 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims 2
- 229960004042 diazoxide Drugs 0.000 claims 2
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 claims 2
- 229960004166 diltiazem Drugs 0.000 claims 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 claims 2
- 239000002702 enteric coating Substances 0.000 claims 2
- 238000009505 enteric coating Methods 0.000 claims 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims 2
- 235000012734 epicatechin Nutrition 0.000 claims 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 2
- 229960002143 fluorescein Drugs 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 claims 2
- 229960004580 glibenclamide Drugs 0.000 claims 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 claims 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims 2
- 229960005045 lidamidine Drugs 0.000 claims 2
- WDRYRZXSPDWGEB-UHFFFAOYSA-N lonidamine Chemical compound C12=CC=CC=C2C(C(=O)O)=NN1CC1=CC=C(Cl)C=C1Cl WDRYRZXSPDWGEB-UHFFFAOYSA-N 0.000 claims 2
- 229960003538 lonidamine Drugs 0.000 claims 2
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 claims 2
- 229960001571 loperamide Drugs 0.000 claims 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 2
- 229960000841 minoxidil sulfate Drugs 0.000 claims 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 claims 2
- 229960001597 nifedipine Drugs 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 229960002281 racecadotril Drugs 0.000 claims 2
- 108700040249 racecadotril Proteins 0.000 claims 2
- KIWUVOGUEXMXSV-UHFFFAOYSA-N rhodanine Chemical class O=C1CSC(=S)N1 KIWUVOGUEXMXSV-UHFFFAOYSA-N 0.000 claims 2
- 150000003384 small molecules Chemical group 0.000 claims 2
- DMRMZQATXPQOTP-GWTDSMLYSA-M sodium;(4ar,6r,7r,7as)-6-(6-amino-8-bromopurin-9-yl)-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol Chemical compound [Na+].C([C@H]1O2)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1Br DMRMZQATXPQOTP-GWTDSMLYSA-M 0.000 claims 2
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 claims 2
- 229960001945 sparteine Drugs 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 150000003505 terpenes Chemical class 0.000 claims 2
- 229960005371 tolbutamide Drugs 0.000 claims 2
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 claims 2
- 229960001722 verapamil Drugs 0.000 claims 2
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 claims 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 claims 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims 1
- SLRCCWJSBJZJBV-LXTVHRRPSA-N (-)-Spartein Natural products C1N2CCCC[C@@H]2[C@H]2CN3CCCC[C@@H]3[C@H]1C2 SLRCCWJSBJZJBV-LXTVHRRPSA-N 0.000 claims 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 claims 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims 1
- XBKIMLQSIXNRRM-UHFFFAOYSA-N (3-phenylpropylamino) benzoate Chemical compound C=1C=CC=CC=1C(=O)ONCCCC1=CC=CC=C1 XBKIMLQSIXNRRM-UHFFFAOYSA-N 0.000 claims 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 claims 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 1
- AVLWBZMAIBWSLR-UHFFFAOYSA-N 3-phenylpropylazanium benzoate Chemical compound OC(=O)C1=CC=CC=C1.NCCCC1=CC=CC=C1 AVLWBZMAIBWSLR-UHFFFAOYSA-N 0.000 claims 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 claims 1
- 244000168525 Croton tiglium Species 0.000 claims 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 claims 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 claims 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 claims 1
- JZFPYUNJRRFVQU-UHFFFAOYSA-N Niflumic acid Chemical compound OC(=O)C1=CC=CN=C1NC1=CC=CC(C(F)(F)F)=C1 JZFPYUNJRRFVQU-UHFFFAOYSA-N 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- 235000021314 Palmitic acid Nutrition 0.000 claims 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims 1
- 229920000124 Prodelphinidin Polymers 0.000 claims 1
- 229930182448 Prodelphinidin Natural products 0.000 claims 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 229930013930 alkaloid Natural products 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 229930014669 anthocyanidin Natural products 0.000 claims 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims 1
- 235000008758 anthocyanidins Nutrition 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 claims 1
- 229960004064 bumetanide Drugs 0.000 claims 1
- 235000007336 cyanidin Nutrition 0.000 claims 1
- 230000013872 defecation Effects 0.000 claims 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 claims 1
- 235000007242 delphinidin Nutrition 0.000 claims 1
- 229930004069 diterpene Chemical class 0.000 claims 1
- 125000000567 diterpene group Chemical class 0.000 claims 1
- 229940030275 epigallocatechin gallate Drugs 0.000 claims 1
- 229930003935 flavonoid Natural products 0.000 claims 1
- 235000017173 flavonoids Nutrition 0.000 claims 1
- 150000002215 flavonoids Chemical class 0.000 claims 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims 1
- 150000002216 flavonol derivatives Chemical class 0.000 claims 1
- 235000011957 flavonols Nutrition 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 1
- 235000020778 linoleic acid Nutrition 0.000 claims 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims 1
- 235000009498 luteolin Nutrition 0.000 claims 1
- 150000002690 malonic acid derivatives Chemical class 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims 1
- 235000007708 morin Nutrition 0.000 claims 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 1
- 229920005615 natural polymer Polymers 0.000 claims 1
- 229960000916 niflumic acid Drugs 0.000 claims 1
- 238000006116 polymerization reaction Methods 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 1
- 235000013824 polyphenols Nutrition 0.000 claims 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims 1
- 229920002414 procyanidin Polymers 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 235000005875 quercetin Nutrition 0.000 claims 1
- 229960001285 quercetin Drugs 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 229930004725 sesquiterpene Chemical class 0.000 claims 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
- 229920001864 tannin Polymers 0.000 claims 1
- 235000018553 tannin Nutrition 0.000 claims 1
- 239000001648 tannin Substances 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79707406P | 2006-05-01 | 2006-05-01 | |
| US60/797,074 | 2006-05-01 | ||
| US11/510,152 | 2006-08-24 | ||
| US11/510,152 US20070254050A1 (en) | 2006-05-01 | 2006-08-24 | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| PCT/US2007/067725 WO2007130882A2 (en) | 2006-05-01 | 2007-04-30 | Method for treatment of diarrhea-predominant irritable bowel syndrome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013171157A Division JP5820440B2 (ja) | 2006-05-01 | 2013-08-21 | 下痢型過敏性腸症候群の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009535417A JP2009535417A (ja) | 2009-10-01 |
| JP2009535417A5 true JP2009535417A5 (enExample) | 2010-06-17 |
| JP5384329B2 JP5384329B2 (ja) | 2014-01-08 |
Family
ID=38648619
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009509982A Active JP5384329B2 (ja) | 2006-05-01 | 2007-04-30 | 下痢型過敏性腸症候群の治療方法 |
| JP2013171157A Active JP5820440B2 (ja) | 2006-05-01 | 2013-08-21 | 下痢型過敏性腸症候群の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013171157A Active JP5820440B2 (ja) | 2006-05-01 | 2013-08-21 | 下痢型過敏性腸症候群の治療方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20070254050A1 (enExample) |
| EP (1) | EP2034844B1 (enExample) |
| JP (2) | JP5384329B2 (enExample) |
| KR (2) | KR101487919B1 (enExample) |
| AR (1) | AR060829A1 (enExample) |
| AU (1) | AU2007248172B2 (enExample) |
| CA (1) | CA2650294C (enExample) |
| DK (1) | DK2034844T3 (enExample) |
| ES (1) | ES2628290T3 (enExample) |
| MX (2) | MX2008013871A (enExample) |
| NZ (2) | NZ595749A (enExample) |
| PE (1) | PE20081569A1 (enExample) |
| PL (1) | PL2034844T3 (enExample) |
| PT (1) | PT2034844T (enExample) |
| SG (1) | SG174025A1 (enExample) |
| TR (1) | TR201708043T4 (enExample) |
| TW (2) | TWI481410B (enExample) |
| WO (1) | WO2007130882A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| NZ572049A (en) | 2006-05-01 | 2012-08-31 | Napo Pharmaceuticals Inc | Method for treatment of constipation-predominant irritable bowel syndrome |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| PT2529626T (pt) | 2006-05-01 | 2018-02-27 | Napo Pharmaceuticals Inc | Composições e métodos para tratamento ou prevenção do cancro do cólon |
| FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| US8436051B2 (en) | 2007-06-08 | 2013-05-07 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
| US8217083B2 (en) * | 2007-06-08 | 2012-07-10 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
| US7541384B2 (en) | 2007-06-08 | 2009-06-02 | Axcan Pharma Inc. | Mesalamine suppository |
| US20110263478A1 (en) * | 2008-09-16 | 2011-10-27 | Simard J Marc | Sur1 inhibitors for therapy |
| JP4565219B2 (ja) * | 2008-12-26 | 2010-10-20 | アサヒビール株式会社 | ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法 |
| AU2010303577B2 (en) * | 2009-10-06 | 2015-10-22 | Napo Pharmaceuticals, Inc. | Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| WO2011073950A1 (en) * | 2009-12-17 | 2011-06-23 | National University Of Singapore | Method of preparing derivatives/oligomers of epicatechin and applications thereof |
| WO2012058664A1 (en) * | 2010-10-31 | 2012-05-03 | Salix Pharmaceuticals, Ltd. | Methods and compositions for treating hiv-associated diarrhea |
| WO2012135702A1 (en) | 2011-04-01 | 2012-10-04 | Ocean Spray Cranberries, Inc. | Inflammation and immunity treatments |
| US20140057993A1 (en) * | 2011-04-27 | 2014-02-27 | Northshore University Healthsystem | Prophylaxis and Treatment of Enteropathogenic Bacterial Infection |
| WO2013161973A1 (en) * | 2012-04-23 | 2013-10-31 | Sucampo Ag | Method for treating irritable bowel syndrome with diarrhea |
| EP2922557B1 (en) | 2012-11-21 | 2017-10-04 | KBS Research, LLC | Herbal supplements and methods of use thereof |
| US9717726B2 (en) | 2013-03-14 | 2017-08-01 | Maregade Rx, LLC | Product and method for treating diarrhea |
| KR101579688B1 (ko) | 2014-07-08 | 2015-12-24 | 재단법인 전남생물산업진흥원 | 좁쌀풀 추출물을 유효성분으로 함유하는 과민성 대장증후군에 의한 내장 통증 억제예방 또는 치료용 약학 조성물 |
| CN104873485B (zh) * | 2015-05-08 | 2019-02-19 | 中国药科大学 | 槲皮素治疗与胃肠道应激失调相关疾病的用途 |
| CN107125440A (zh) * | 2016-02-29 | 2017-09-05 | 湖南晶天科技实业有限公司 | 一种饲料添加剂肠溶包衣单宁酸及其制备方法以及一种饲料 |
| IT201600122310A1 (it) | 2016-12-01 | 2018-06-01 | Sofar Spa | Composizione per uso nella terapia di alterazioni dell'intestino |
| US20180185356A1 (en) | 2016-12-23 | 2018-07-05 | Maregade Rx, LLC | Low dose product and method for treating diarrhea |
| EP3592333B1 (en) * | 2017-03-06 | 2024-04-03 | Athena Pharmaceutiques SAS | A pharmaceutical composition comprising racecadotril and process for preparing the same |
| AU2018275685B2 (en) | 2017-05-31 | 2025-04-17 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome |
| JP2020525407A (ja) * | 2017-05-31 | 2020-08-27 | ナポ ファーマシューティカルズ インク．Ｎａｐｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 先天性下痢障害を治療するための方法及び組成物 |
| KR20220046544A (ko) * | 2019-06-12 | 2022-04-14 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 답즙산 설사를 치료하는 방법 |
| CN113975412B (zh) * | 2021-12-30 | 2022-04-05 | 北京赛尔富森生物科技有限公司 | 一种评价轮状病毒疫苗有效性的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE446940B (sv) | 1983-02-16 | 1986-10-20 | Carl Axel Virdalm | Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter |
| US4698360B1 (en) | 1985-04-09 | 1997-11-04 | D Investigations Pharmacologiq | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
| EP0214317B1 (fr) | 1985-08-30 | 1988-08-17 | Societe Des Produits Nestle S.A. | Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation |
| US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| SI9011933A (sl) | 1990-10-15 | 1998-06-30 | TANIN SEVNICA Kemična industrija p.o. | Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba |
| US5234922A (en) | 1992-09-28 | 1993-08-10 | University Of Iowa Research Foundation | Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea |
| FI962667A7 (fi) | 1996-06-27 | 1997-12-28 | Oy Scanwoven Ab | Kuitutuote, menetelmä ja laitteisto kuitutuotteen valmistamiseksi |
| JP4195728B2 (ja) | 1996-10-16 | 2008-12-10 | ナポ ファーマシューティカルズ，インコーポレーテッド | プロアントシアニジンポリマー止瀉組成物の腸溶製剤 |
| AU6967198A (en) | 1997-04-10 | 1998-10-30 | Eli Lilly And Company | Diarylsulfonylureas for use in treating secretory diarrhea |
| US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| WO2000047062A2 (en) * | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
| US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
| US20040063695A1 (en) | 2002-09-30 | 2004-04-01 | Alan Verkman | Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| US7208183B2 (en) * | 2002-10-05 | 2007-04-24 | Bobrowski Paul J | Methods and preparations of the latex from the croton species |
| US7303772B2 (en) * | 2005-11-10 | 2007-12-04 | Olalde Rangel Jose Angel | Synergistic phytoceutical compositions |
| PT2529626T (pt) | 2006-05-01 | 2018-02-27 | Napo Pharmaceuticals Inc | Composições e métodos para tratamento ou prevenção do cancro do cólon |
| NZ572049A (en) * | 2006-05-01 | 2012-08-31 | Napo Pharmaceuticals Inc | Method for treatment of constipation-predominant irritable bowel syndrome |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| US7928115B2 (en) | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
| AU2010303577B2 (en) | 2009-10-06 | 2015-10-22 | Napo Pharmaceuticals, Inc. | Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| WO2012058664A1 (en) | 2010-10-31 | 2012-05-03 | Salix Pharmaceuticals, Ltd. | Methods and compositions for treating hiv-associated diarrhea |
| JP2016505561A (ja) | 2012-12-07 | 2016-02-25 | サリックス ファーマスーティカルズ，リミテッド | Ｈｉｖ関連下痢を治療する方法および組成物 |
-
2006
- 2006-08-24 US US11/510,152 patent/US20070254050A1/en not_active Abandoned
-
2007
- 2007-04-30 PT PT77615417T patent/PT2034844T/pt unknown
- 2007-04-30 ES ES07761541.7T patent/ES2628290T3/es active Active
- 2007-04-30 KR KR20137013965A patent/KR101487919B1/ko active Active
- 2007-04-30 KR KR1020087029446A patent/KR101537361B1/ko active Active
- 2007-04-30 TW TW096115334A patent/TWI481410B/zh active
- 2007-04-30 TW TW103119392A patent/TWI574694B/zh not_active IP Right Cessation
- 2007-04-30 WO PCT/US2007/067725 patent/WO2007130882A2/en not_active Ceased
- 2007-04-30 DK DK07761541.7T patent/DK2034844T3/en active
- 2007-04-30 AU AU2007248172A patent/AU2007248172B2/en active Active
- 2007-04-30 SG SG2011055233A patent/SG174025A1/en unknown
- 2007-04-30 TR TR2017/08043T patent/TR201708043T4/tr unknown
- 2007-04-30 CA CA2650294A patent/CA2650294C/en active Active
- 2007-04-30 MX MX2008013871A patent/MX2008013871A/es active IP Right Grant
- 2007-04-30 NZ NZ595749A patent/NZ595749A/xx unknown
- 2007-04-30 MX MX2014006240A patent/MX382400B/es unknown
- 2007-04-30 JP JP2009509982A patent/JP5384329B2/ja active Active
- 2007-04-30 EP EP07761541.7A patent/EP2034844B1/en active Active
- 2007-04-30 NZ NZ609344A patent/NZ609344A/en unknown
- 2007-04-30 PL PL07761541T patent/PL2034844T3/pl unknown
- 2007-05-02 AR ARP070101888A patent/AR060829A1/es unknown
- 2007-05-02 PE PE2007000533A patent/PE20081569A1/es not_active Application Discontinuation
-
2011
- 2011-11-25 US US13/304,604 patent/US8846113B2/en active Active
-
2013
- 2013-08-21 JP JP2013171157A patent/JP5820440B2/ja active Active
-
2014
- 2014-08-22 US US14/466,089 patent/US9980938B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ramesh et al. | Herbs as an antioxidant arsenal for periodontal diseases | |
| CN100544715C (zh) | 作为治疗剂的包含无取代b环类黄酮和黄烷混合物的组合物 | |
| US7972632B2 (en) | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors | |
| NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
| KR20030036648A (ko) | 호흡기에 관련된 일반 감기, 알레르기성 비염 및 감염증상의 치료 방법 | |
| CN1219390A (zh) | 新的用于控制和治疗肛门直肠和结肠疾病的药物组合物 | |
| BR0213522B8 (pt) | compostos derivados de hidroxipirimidinona, composição farmacêutica, e, uso de um composto | |
| JP2007515423A5 (enExample) | ||
| US6759064B2 (en) | Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer | |
| JP2004516257A (ja) | 糖尿病性神経障害の治療に対する組成物及びその方法 | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| AU2002254007A1 (en) | Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer | |
| US20090239943A1 (en) | Nutraceutical composition and methods for its use | |
| JP5519906B2 (ja) | 肝臓疾患の支持療法 | |
| WO2006106308A1 (en) | Therapeutic use of nefopam and analogues thereof | |
| WO2006032115A3 (en) | Composition against cardiovascular diseases | |
| US20070287685A1 (en) | Medicinal composition containing FBPase inhibitor | |
| JP5101521B2 (ja) | メチシリン耐性黄色ブドウ球菌をオキサシリンに対し感作する組成物および方法 | |
| JP2008543902A5 (enExample) | ||
| US20040142048A1 (en) | Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer | |
| JP2008533023A5 (enExample) | ||
| WO2006085127A1 (en) | Topical compositions | |
| WO2002067965A1 (en) | Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer | |
| US20050165090A1 (en) | Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation | |
| CA2486704A1 (en) | Anti-cancer formulation |